Intellia Therapeutics, Inc. Share Price

Intellia Therapeutics, Inc. Share Price

NASDAQ: NTLA | Small Cap
$12.47
-$0.76 (-5.74%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Intellia Therapeutics, Inc. Stock Performance

Open
$13.02
Prev. Close
$13.23
Circuit Range
N/A
Day Range
$12.04 - $13.11
Year Range
$7.95 - $18.48
Volume
2,81,034
Average Traded
$12.34

Intellia Therapeutics, Inc. Share Price Today

As of 31 October 2026, Intellia Therapeutics, Inc.'s share price is $12.47. The stock opened at $13.02, compared to its previous close of $13.23. During today's trading session, Intellia Therapeutics, Inc.'s share price traded between $12.04 and $13.11, with an average price of $12.58. Over the past 52 weeks, the stock has recorded a high of $18.48 and a low of $7.95. In terms of performance, Intellia Therapeutics, Inc.'s share price has declined by 7.39% over the last six months and is down 1.15% on a year-on-year basis.

Intellia Therapeutics, Inc. Share Price Chart

Line chart of the Intellia Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 12.04 to 12.67, ending at 12.46.
$12.04$13.11
L
Show Current Price
H

Intellia Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.35B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.85
Revenue (TTM)
$67.67B
Return On Equity (TTM)
-54.96%
Profit Margin
-609.86%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-5.24%

Intellia Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$13.78$23.02$15.05$7.66
Net Profit-$101.32-$95.79-$96.23-$106.63
Net Profit Margin-735.27%-416.12%-639.40%-1392.04%
Income ChangeN/A5.46%-0.46%-10.81%

Intellia Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$52.12$36.28$57.88$67.67
Net Profit-$474.19-$481.19-$519.02-$412.69
Net Profit Margin-909.80%-1326.32%-896.72%-609.86%
Income ChangeN/A-1.48%-7.86%20.49%

About Intellia Therapeutics, Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Intellia Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$11.90
$12.46
+3.23%
Sep 2026
$12.54
$12.06
-7.90%
Aug 2026
$10.64
$13.10
+22.66%
Jul 2026
$17.15
$10.68
-36.92%
Jun 2026
$13.78
$16.93
+20.33%
May 2026
$13.27
$14.07
+4.49%
Apr 2026
$13.03
$13.46
+5.11%
Mar 2026
$13.80
$12.81
-7.04%
Feb 2026
$13.01
$13.78
+4.91%
Jan 2026
$9.21
$13.13
+46.27%
Dec 2025
$8.72
$8.98
-0.11%
Nov 2025
$13.07
$8.99
-28.74%

NTLA Share Price FAQs